Market Tracker

06/24 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.48
Delayed Data
As of Jun 24
 -0.30 / -6.28%
Today’s Change
3.61
Today|||52-Week Range
11.15
-26.92%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close4.78
Today’s open4.50
Day’s range4.45 - 4.66
Volume1,260,453
Average volume (3 months)854,081
Market cap$334.3M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+117.41%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.12+2.03%
VSARVersartis Inc-1.06-9.19%
NLNKNewLink Genetics Cor...-0.90-8.01%
TRVNTrevena Inc+0.18+2.90%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts